Wed, Feb 26, 12:10 PM (63 days ago)
**Enovis Corporation (ENOV) 2024 Financial Summary** Enovis Corporation reported a significant increase in net sales, reaching $2,107.6 million for the year ending December 31, 2024, a 23.5% rise from 2023, driven by acquisitions, particularly the Lima acquisition, which contributed $322.5 million in sales. The company incurred a net loss from continuing operations of $827.4 million, largely due to a goodwill impairment charge of $645 million and increased strategic transaction costs. Adjusted EBITDA improved to $376.5 million, reflecting a margin of 17.9%. Operating expenses rose to $1,027.4 million, influenced by higher commissions, integration costs, and inflationary pressures. The company’s balance sheet showed total assets of $4.72 billion, with goodwill of $1.69 billion post-impairment. Enovis maintains a strong liquidity position with $48.2 million in cash and a $900 million revolving credit facility. Strategically, Enovis is focused on expanding its market presence and enhancing product offerings through acquisitions and innovation. However, risks include regulatory challenges, supply chain disruptions, and market competition. The future outlook hinges on successful integration of recent acquisitions and navigating economic uncertainties. **Key Figures**: - **Revenue**: $2,107.6 million - **Net Income**: $(827.4) million - **Adjusted EBITDA**: $376.5 million - **Goodwill**: $1.69 billion - **Total Assets**: $4.72 billion